Distribution of specific high-affinity binding sites for [3H]imipramine in human brain. 1981

S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid

[3H]Imipramine binds with high affinity to membranes from different regions of the human brain. The highest density of binding sites was observed in the hypothalamus and substantia nigra and the lowest density in the white matter and cerebellum. As found in rat brain, tricyclic antidepressant drugs are potent inhibitors of [3H]imipramine binding. Atypical antidepressants are, however, much weaker at inhibiting the specific binding. The [3H]imipramine binding site in human cortex is apparently identical to the site already described in the rat brain and in human platelets.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical

Related Publications

S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
January 1997, Journal of neural transmission (Vienna, Austria : 1996),
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
June 1980, Life sciences,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
March 1980, Life sciences,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
October 1979, European journal of pharmacology,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
May 1984, Biochemical and biophysical research communications,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
February 1980, European journal of pharmacology,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
January 1982, Psychopharmacology,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
November 1986, Brain research,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
February 1983, European journal of pharmacology,
S Z Langer, and F Javoy-Agid, and R Raisman, and M Briley, and Y Agid
January 1997, Journal of neural transmission (Vienna, Austria : 1996),
Copied contents to your clipboard!